Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen touts new dosing option for underperforming cholesterol drug
Amgen touts new dosing option for underperforming cholesterol drug
Amgen touts new dosing option for underperforming cholesterol drug
Submitted by
admin
on July 13, 2016 - 4:04pm
Source:
BioPharma Dive
News Tags:
Amgen
Repatha
PCSK9 inhibitors
Headline:
Amgen touts new dosing option for underperforming cholesterol drug
Do Not Allow Advertisers to Use My Personal information
